Updates on Dengue Vaccine and Antiviral: Where Are We Heading?
Approximately 100–400 million people from more than 100 countries in the tropical and subtropical world are affected by dengue infections. Recent scientific breakthroughs have brought new insights into novel strategies for the production of dengue antivirals and vaccines. The search for specific den...
Enregistré dans:
Auteurs principaux: | Harun Norshidah, Ramachandran Vignesh, Ngit Shin Lai |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/dc66ccf0fba94e56aa7bec795ec99b09 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Diterpenes/Diterpenoids and Their Derivatives as Potential Bioactive Leads against Dengue Virus: A Computational and Network Pharmacology Study
par: Rasel Ahmed Khan, et autres
Publié: (2021) -
Occurrence of Dengue Virus Infection with Multiple Serotypes at Central Karnataka, India
par: VinodKumar CS, et autres
Publié: (2021) -
A Critical Role for Perivascular Cells in Amplifying Vascular Leakage Induced by Dengue Virus Nonstructural Protein 1
par: Yin P. Cheung, et autres
Publié: (2020) -
NS1-based ELISA test efficiently detects dengue infections without cross-reactivity with Zika virus
par: Samuel Santos Pereira, et autres
Publié: (2021) -
Efficient Control of Zika Virus Infection Induced by a Non-Replicating Adenovector Encoding Zika Virus NS1/NS2 Antigens Fused to the MHC Class II-Associated Invariant Chain
par: Loulieta Nazerai, et autres
Publié: (2021)